drugset / Trial / NCT00866918
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This phase III trial is studying combination chemotherapy to see how well it works in treating young patients with newly diagnosed acute promyelocytic leukemia. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells.
Timeline
- Start
- 2009-03-09
- Primary completion
- 2015-06-30
- Completion
- 2022-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cytarabine | Small molecule | — | Intrathecal |
| Subject | Idarubicin | Small molecule | — | Intravenous |
| Subject | MERCAPTOPURINE ANHYDROUS | Small molecule | — | Oral |
| Subject | Methotrexate | Small molecule | — | Oral |
| Subject | Mitoxantrone | Small molecule | — | Intravenous |
| Subject | Tretinoin | Small molecule | — | Oral |
| Subject | arsenic trioxide | Small molecule | — | Intravenous |